Dr. Prashant Mehta is a highly distinguished Medical Oncologist, Haemato-Oncologist, and Bone Marrow Transplant physician with over 16 years of elite clinical experience. Currently serving at Amrita Hospital, Faridabad, he is recognized as a pioneer in the region, having performed the first successful Bone Marrow Transplant, the first Total Body Irradiation (TBI)-based transplant, and the first Matched Unrelated Donor (MUD) transplant in Faridabad. An alumnus of AIIMS, New Delhi, Dr. Mehta is at the forefront of the CAR-T Cell Therapy program in India, bringing revolutionary cellular treatments to patients with relapsed blood cancers.
Dr. Prashant Mehta is celebrated for his commitment to clinical innovation and his mission to make advanced cancer therapies accessible to patients globally.
- Elite Academic Foundation: He completed his super-specialization (DM in Medical Oncology) at the All India Institute of Medical Sciences (AIIMS), New Delhi, the country’s apex medical institute. This rigorous training was followed by a prestigious Visiting Physician Fellowship at the Fred Hutchinson Cancer Research Center in Seattle, USA, one of the world’s leading centers for transplant and cellular research.
- Master of CAR-T Cell Therapy: Dr. Mehta leads the cellular therapy program at Amrita, focusing on making CD19-targeted CAR-T therapy—a “living drug” that reprogrammes the patient’s immune system—available for refractory leukemias and lymphomas.
- Transplant Innovation: He is a master of Haploidentical (Half-Matched) Transplants and Reduced Toxicity Conditioning, ensuring that even older or more fragile patients can safely undergo curative bone marrow procedures.
- Advocate for Patient-Centric Care: As a founder member of the Science and Cost Cancer Consortium, he works tirelessly to develop scientific strategies that improve the accessibility and affordability of cancer care without compromising on world-class outcomes.
Dr. Mehta provides a comprehensive, multi-disciplinary approach to treating both solid tumors and high-risk blood cancers in children and adults.
Conditions & Diseases Treated:
- Blood Cancers: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), and Multiple Myeloma.
- Lymphomas: Hodgkin’s and Non-Hodgkin’s Lymphoma (including NK/T cell Lymphoma).
- Solid Tumors: Lung Cancer, Ovarian Cancer, Sarcomas, and Melanoma.
- Pediatric Oncology: Childhood leukemias and solid tumors.
- Complex Deformities: Management of advanced Head and Neck cancers using metronomic therapy.
Specialized Interventional Procedures:
- Bone Marrow Transplantation (BMT): Expertise in Autologous, Allogeneic, MUD, and Haploidentical transplants.
- CAR-T Cell Therapy: Advanced cellular therapy for relapsed/refractory B-cell malignancies.
- Precision Oncology: Utilizing molecular profiling to select targeted therapies and checkpoint inhibitors.
- Total Body Irradiation (TBI) Transplants: Utilizing specialized radiation protocols for high-risk leukemia conditioning.
- Immunotherapy: Advanced use of PD-1, PD-L1, and CTLA-4 inhibitors for various cancers.
Dr. Mehta’s career is marked by his association with India’s most elite oncology centers:
- Senior Associate Director & Program Head: Amrita Hospital, Faridabad (Current).
- Consultant (Oncology & BMT): Artemis Health Institute, Gurugram.
- Senior Resident (Oncology & BMT): All India Institute of Medical Sciences (AIIMS), New Delhi.
- Founder Member: Science and Cost Cancer Consortium (aimed at improving global access to cancer care).
Awards & Recognitions
- Prof. G.S. Bhattacharya Memorial Award (2021): Honored as the “Best All-Rounder Oncologist in India” by the Indian Cooperative Oncology Network (ICON).
- Meghna Krishna Baweja Award: Recognized for all-round excellence during his foundational training at Maulana Azad Medical College.
- Academic Contributor: Published over 60 research papers in high-impact international journals and served as the Joint Editor for the Indian Journal of Medical and Paediatric Oncology (IJMPO).
- Global Speaker: Regularly invited to present research at international forums like ESMO Asia (Singapore).
- DM (Medical Oncology): All India Institute of Medical Sciences (AIIMS), New Delhi.
- Visiting Physician Fellowship (BMT/Cellular Therapy): Fred Hutchinson Cancer Research Center, Seattle, USA.
- MD (General Medicine): Lady Hardinge Medical College (LHMC), New Delhi.
- MBBS: Maulana Azad Medical College (MAMC), New Delhi.
- Certification: European Society for Medical Oncology (ESMO) Certified.
